Immune overreaction may enable recurrent urinary tract infections

Aug 12, 2010

The immune system may help open the door to recurrent urinary tract infections (UTIs) by overdoing its response to an initial infection, report researchers at Washington University School of Medicine in St. Louis. The findings appear August 12 in the open-access journal PLoS Pathogens.

Using a , the researchers demonstrated that severe inflammatory responses to an initial UTI cause bladder damage and allow to persist longer. In support of this, they found that immunodeficient mice lacking these acute inflammatory responses were protected from chronic bladder infection. Finally, they demonstrated that mice with a history of chronic bladder infection that was subsequently cleared with develop persistent immune cell infiltrations within the bladder wall, and these mice are highly susceptible to further UTI.

"We found markers in the mice that may one day help us identify patients vulnerable to recurrent infection and refine our treatment strategies," says lead author Thomas J. Hannan, DVM, PhD. "There were infection-fighting elements in the responses of some mice that we might, for example, be able to promote through vaccines for these patients."

UTIs affect millions of people each year, the authors note. Although antibiotic therapy has historically been helpful, is a rapidly increasing concern, according to Scott Hultgren, PhD, director of the Center for Women's Infectious Diseases Research, where the experiments were conduced.

"Women and infants are at greatest risk for having a UTI, and chronic and recurrent infections are common," says Hultgren. "UTIs are estimated to cause around $1.6 billion in medical expenses every year in the United States."

Explore further: Researchers take 'first baby step' toward anti-aging drug

add to favorites email to friend print save as pdf

Related Stories

Chronic infection may add to developing-world deaths

Feb 12, 2009

Worldwide, nearly 2 million people per year die from diarrhea, the vast majority of them in poor countries in Africa and Asia. The disease accounts for 18 percent of all deaths among children — and yet is almost always ...

Recommended for you

Biomedical team creates 'nerve on a chip'

Dec 24, 2014

Michael J. Moore and J. Lowry Curley first met in the laboratory as professor and student. Now the two Tulane University researchers have started a new biomedical company that's winning praise and awards.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.